IMR Press / EJGO / Volume 23 / Issue 4 / pii/2002174

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII

Show Less
1 Division of Gynecological Surgery, Department of Gynecology and Obstetrics, Karol Marcinkowski University of Medical Sciences, Poznan (Poland)
Eur. J. Gynaecol. Oncol. 2002, 23(4), 325–326;
Published: 10 August 2002
Abstract

The authors report two cases of successful employment of human recombinant activated factor VII in gynecological oncological patients (endometrial cancer and vaginal sarcoma) without pre-existing coagulopathy. They conclude that recombinant factor VIIa may be an important and effective drug in severe bleeding in gynecological oncology.

Keywords
Recombinant factor Vila
Coagulation
Hemorrhage
Cancer of endometrium
Vaginal sarcoma
Share
Back to top